skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi there, can AIDX be considered dead on arrival now, for its IPO possibility next year?

The share price action has brought it down considerably during this tax loss selling season!

Where do you see support for the shares now?

Do you consider the shares priced fairly here at 1.00?

Current growth and outlook looks good, share price not so much, horrible!

I believe my question on WGX last week has gone MIA...your thoughts on their last quarter please?

Thanks!
Read Answer Asked by Hussein on November 25, 2025
Q: This healthcare tech stock just reported earnings, and appears to have beat on all marks. Yet the stock has dropped significantly since reporting. Wondering if you could give me your analysis if this is a good opportunity to buy relative to other healthcare tech, given its valuation metrics, support and resistance, and current growth trajectory. Any other similar small cap names in healthcare like this intrigue you right now?
Read Answer Asked by Thomas on November 14, 2025
Q: TLT has recently announced promising results for Rutherin, the molecule it is testing. E.g. "Enhanced Tumor Destruction: Radiation-activated Rutherrin® achieved a 100-fold increase in cancer cell kill versus radiation therapy alone." But it is tiny, with a multi-year path to final results and depends on raising further capital. How can an investor assess companies like this, and what is your opinion of TLT re getting an investment toe in the door?
Read Answer Asked by John on November 12, 2025